Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of ABT-751 in Patients With Refractory Hematologic Malignancies
This study has been terminated.
Study NCT00047489   Information provided by M.D. Anderson Cancer Center
First Received: October 8, 2002   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hematological Malignancies
Additional conditions recognized in this trial
Hematologic Neoplasms
Neoplasms
More general conditions related to this trial
Hematologic Diseases
Neoplasms by Site
Interventions listed in this trial
ABT-751
Sponsors listed in this trial
M.D. Anderson Cancer Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services